Publications by authors named "Christopher B Hopson"

Claim this Profile
A
Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint Blockade.
Sapna Yadavilli, Jeremy D Waight, Sara Brett, Meixia Bi, Tianqian Zhang, Christopher B Hopson

Cancer Res Commun· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immuno-PET Monitoring of CD8 T Cell Infiltration Post ICOS Agonist Antibody Treatment Alone and in Combination with PD-1 Blocking Antibody Using a Zr Anti-CD8 Mouse Minibody in EMT6 Syngeneic Tumor Mouse.
Hasan Alsaid, Shih-Hsun Cheng, Meixia Bi, Fang Xie, Mary Rambo, Christopher B Hopson

Mol Imaging Biol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Design of amidobenzimidazole STING receptor agonists with systemic activity.
Joshi M Ramanjulu, G Scott Pesiridis, Jingsong Yang, Nestor Concha, Robert Singhaus, Christopher B Hopson

Nature· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments.
Jong W Yu, Sabyasachi Bhattacharya, Niranjan Yanamandra, David Kilian, Hong Shi, Christopher B Hopson

PLoS One· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of amidobenzimidazole STING receptor agonists with systemic activity.
Joshi M Ramanjulu, G Scott Pesiridis, Jingsong Yang, Nestor Concha, Robert Singhaus, Christopher B Hopson

Nature· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist.
Connie L Erickson-Miller, Evelyne Delorme, Shin-Shay Tian, Christopher B Hopson, Amy J Landis

Stem Cells· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New benzimidazoles as thrombopoietin receptor agonists.
Igor G Safonov, Dirk A Heerding, Richard M Keenan, Alan T Price, Connie L Erickson-Miller, Christopher B Hopson

Bioorg Med Chem Lett· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist.
Connie L Erickson-Miller, Evelyne DeLorme, Shin-Shay Tian, Christopher B Hopson, Kenneth Stark

Exp Hematol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of Siglec-5 (CD170) expression and functional activity of anti-Siglec-5 antibodies on human phagocytes.
Connie L Erickson-Miller, Sylvie D Freeman, Christopher B Hopson, Karla J D'Alessio, Elizabeth I Fischer

Exp Hematol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis